The company presented its results this week at a conference and anticipates that with additional validation early next year it will be ready to file for regulatory approval.

The company will use the money to advance the development and commercialization of its liquid biopsy cancer detection panels.

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Justin Hanson operated a kickback scheme in which he paid the owner of a Milwaukee substance abuse treatment clinic kickbacks for urine drug testing referrals.

The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

Top Five Articles on 360Dx Last Week: Qiagen, BioMérieux Lawsuit; T2 Biosystems Post-Mortem; More ...

The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.

The company raised $57.5 million in February through a public offering, and the proceeds will be used to support commercial expansion in the US and EU.

UK Prime Minister Keir Starmer announced last week his plans to scrap the body, a dozen years after it was established to ...

The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.